Patents by Inventor Hans Gühring

Hans Gühring has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HIGHLY BRIDGED PEPTIDES FROM ACTINOMADURA NAMIBIENSIS
    Publication number: 20110144001
    Abstract: The invention refers to so-called Labyrinthopeptin derivatives of the formula (I) wherein {A}, {B}, {C}, R1-R6, m and n are as defined herein, obtainable from microorganism strain Actinomadura namibiensis (DSM 6313), its use for the treatment of bacterial infections, viral infections and/or pain, a pharmaceutical composition comprising it, prepro-Labyrinthopeptin, pro-Labyrinthopeptin, and DNA coding for prepro-Labyrinthopeptin and pro-Labyrinthopeptin.
    Type: Application
    Filed: September 30, 2010
    Publication date: June 16, 2011
    Applicant: SANOFI-AVENTIS
    Inventors: Mark BROENSTRUP, Hans GUEHRING, Holger HOFFMANN, Joachim WINK, Roderich SUESSMUTH, Timo SCHMIEDERER
  • Use of sulfonyl-substituted 2-sulfonylaminobenzoic acid N-phenylamides in the treatment of pain
    Publication number: 20110021505
    Abstract: The present invention relates to the use of sulfonyl-substituted 2-sulfonylaminobenzoic acid N-phenylamides of the formula I, wherein A and R1 to R6 have the meanings indicated in the claims, for treating pain and for manufacturing a medicament for the treatment of pain.
    Type: Application
    Filed: March 30, 2010
    Publication date: January 27, 2011
    Applicant: SANOFI-AVENTIS DEUTSCHLAND GMBH
    Inventors: Karl RUDOLPHI, Martin MICHAELIS, Hans GUEHRING
  • NOVEL PEPTIDES FROM ACTINOMADURA NAMIBIENSIS
    Publication number: 20090298904
    Abstract: The disclosure relates to a compound of the formula (I) wherein m and n are independently of one another 0, 1 or 2, obtainable from Actinomadura namibiensis (DSM 6313), its use for the treatment of bacterial infections, viral infections and/or pain, and pharmaceutical composition comprising it.
    Type: Application
    Filed: April 2, 2009
    Publication date: December 3, 2009
    Applicant: sanofi-aventis
    Inventors: Gerhard Seibert, László Vértesy, Joachim Wink, Irvin Winkler, Mark Broenstrup, Holger Hoffmann, Hans Guehring, Luigi Toti, Roderich Süssmuth, George M. Sheldrick, Kathrin Meindl